Herceptin for HER2-positive breast cancer improves long-term survival

[News]

A new study shows that when added to chemotherapy, trastuzumab - commonly known as Herceptin - significantly improves long-term survival of HER2-positive breast cancer patients.

More... (http://www.medicalnewstoday.com/articles/287021.php)